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Mechanical ventilation (MV) is the second most frequent 
therapeutic intervention performed in ICUs (after treat-
ment of cardiac arrhythmias), and is the most important 
intervention in patients with respiratory failure. However, 
it is associated with several complications, including 
increased risk of pneumonia, impaired cardiac function, 
and development of lung injury. Th   ere is now unequivocal 
evidence from both experimental and clinical studies that 
MV can cause or aggravate acute lung injury (ALI) - a 
concept termed ventilator-induced lung injury (VILI). 
Many of the pathophysiological consequences of VILI 
mimic those of acute respiratory distress syndrome 
(ARDS) [1]. Is this relationship a coincidence or could 
there be a more sinister explanation - we address this 
issue later in this commentary.
In the 1960s, pathologists recognized a new, severe 
pulmonary lesion that they called ‘respirator lung’; in the 
1970s Webb and Tierney developed a model of VILI [2], 
and in the late 1980s Dreyfuss and colleagues determined 
that lung stretch was a critical factor leading to VILI [1]. 
In 1998 Tremblay and Slutsky [3] coined the term 
‘biotrauma’ to describe the pulmonary and systemic 
inﬂ  ammatory response triggered by lung cell distension, 
disruption, and/or necrosis after the appli  cation of MV. 
Although a Consensus Conference in 1994 recommended 
that plateau pressure should generally be limited to 35 
cmH2O [4], little change in ventilator practice occurred 
until publication of the ARDS Network study [5], which 
demonstrated that a lung protective strategy using a tidal 
volume (VT) of 6 ml/kg predicted body weight decreased 
mortality in patients with ALI. Th   is study conﬁ  rmed that 
VILI was not just an interesting experimental entity, but 
was also an important clinical problem. Th   is study led to 
the widespread, albeit not universal, use of lung 
protective strategies in patients with ALI.
However, the ARDS Network trial did not address the 
issue of how to ventilate patients who do not have ALI 
[6]. On the one hand, one could argue that such a strict 
lung protective strategy using small tidal volumes is not 
necessary as these patients do not have widespread 
pulmonary changes observed in patients with ALI and 
are therefore not at great risk of VILI. Furthermore, the 
use of low VT might lead to de-recruitment of lung units, 
increased hypoxemia and hypercapnia. On the other 
hand, the upper limit of plateau pressure that ensures 
lung protection may be substantially lower than 
30 cmH2O, and small VT may be beneﬁ  cial [7]. Evidence 
that lower VT may be advantageous in patients without 
ALI has been provided by observational studies 
demonstrating that ventilation with higher VTs early in 
the ICU course is associated with subsequent develop-
ment of ALI [8,9]. However, observational studies are 
prone to bias, particularly because it is not clear why the 
attending physician chose a large versus small VT for any 
given patient. As such, a randomized trial addressing the 
hypothesis that a small VT could prevent or attenuate 
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In this month’s issue of Critical Care, Determann 
and colleagues report the results of a randomized 
controlled trial comparing the eff  ects of mechanical 
ventilation (MV) with two tidal volumes (6 versus 
10 ml/kg predicted body weight) on cytokine levels 
in lung lavage fl  uid and plasma as a surrogate for 
early identifi  cation of acute lung injury (ALI) and/
or acute respiratory distress syndrome (ARDS). The 
study was stopped early after an interim analysis - 
when 150 patients were enrolled - showing that 
the incidence of ALI/ARDS according to the current 
defi  nition was 10.9% higher in the 10 ml/kg group, 
although duration of MV and mortality was similar in 
both groups. We examine these interesting results after 
providing a brief historical perspective and discuss the 
limitations and implications of the study.
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In this issue of Critical Care, Determann and colleagues 
[10] report the results of a randomized controlled trial 
comparing two VTs (6 versus 10 ml/kg predicted body 
weight) in ventilated patients without ALI. Broncho-
alveolar lavage ﬂ  uid and plasma cytokine levels were used 
as surrogate endpoints for early identiﬁ   cation of the 
pulmonary inﬂ  ammation associated with ALI. Th  e  study 
was stopped prematurely after the second interim 
analysis (n = 150 patients) because investigators from one 
of the two participating centres were uncomfortable 
continuing the study since the development of ALI was 
signiﬁ  cantly greater in the control arm. Methodologically, 
this is somewhat unusual in that current practice is that 
interim analyses are carried out by a committee who are 
not investigators in the study [11]; indeed, it is 
uncommon for investigators to even be aware of interim 
outcome data by study group. We think that stopping the 
trial early was unnecessary and unfortunate; there was no 
strong safety signal, with virtually identical trends in 
terms of duration of MV and mortality rate in both 
groups. Early stopping tends to overestimate treatment 
eﬀ  ects [12,13]; this is particularly true for studies with 
low event rates, as was the case in this study, in which 
only 12 patients in total developed ALI.
What conclusions can be drawn from the paper by 
Determann and colleagues? First, there are insuﬃ   cient 
data to conclude that all ICU patients must be ventilated 
with a VT of 6 ml/kg. We agree with the authors who 
recommend that a large randomized controlled trial is 
needed before being able to draw this conclusion. 
Nonetheless, using small VTs in patients without ALI may 
be a reasonable strategy, and there appears to be little 
evidence of harm if clinicians address issues related to 
maintenance of suﬃ   cient  positive  end-expiratory 
pressure (PEEP), and possibly the respiratory acidosis 
that may arise.
Second, as hinted at above, it is interesting to speculate 
on the relationship between MV and ALI. If Determann 
and colleagues’ data are correct, should we begin to 
consider that ALI/ARDS is a consequence of our eﬀ  orts 
to ventilate patients, rather than progression of the 
underlying disease [14]? Injurious ventilatory strategies 
have been shown to increase alveolar-capillary leak, 
worsen oxygenation, cause pulmonary inﬁ  ltrates, decrease 
lung compliance and cause an increase in lavage and 
systemic cytokines - all hallmarks of ALI/ARDS. In the 
context of increased alveolar-capillary leak, use of 
excessive intravenous ﬂ  uids - often used to treat shock in 
patients at risk for ALI - can cause increased lung water, 
and again worsen mechanics and gas exchange, and 
indeed worsen clinical outcomes. It may not be a 
coincidence that ARDS was ﬁ  rst described in the late 
1960s, at the time of the Vietnam war - it is also called 
‘Da Nang lung’ or ‘shock lung’ - when patients were 
resuscitated aggressively on the battle-ﬁ  eld.  Finally, 
endotracheal intubation aﬀ  ects host defence and can lead 
to development of colonization/pneumonia, a predis-
posing factor for ALI. As such, is ALI/ARDS largely a 
‘man-made’ syndrome, and is it a consequence of the 
aggressive regimens we have adopted to treat acutely ill 
patients? If so, and if the results of Determann and 
colleagues vis-à-vis the marked decrease in development 
of ALI in patients treated with low VT turns out to be 
correct, it would mark an inﬂ  ection point in which ALI/
ARDS is no longer a syndrome that must be treated, but 
is a syndrome that should be prevented.
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